Nicox develops pharmaceuticals using recently discovered properties of nitric oxide. The Company develops drugs-candidates for the potential treatment of inflammatory, cardiometabolic and ophthalmological diseases. Nicox's lead compound naproxcinod is developed for the relief of the signs and symptoms of osteoarthritis.
1681 Route Des Dolines
Taissounieres HB4 BP 313